Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy

Type II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. While conventional antihyperglycemic medications like biguanides, sulfonylureas, and other agents are commonly used, their long-term use can have side effects, prompting researc...

Full description

Saved in:
Bibliographic Details
Main Authors: Oluwaseye Adedirin, Rukayat A. Abdulsalam, Khadeejah O. Nasir-Naeem, Ayenitaju A. Oke, Akolade O. Jubril, Saheed Sabiu
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402500619X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087571975372800
author Oluwaseye Adedirin
Rukayat A. Abdulsalam
Khadeejah O. Nasir-Naeem
Ayenitaju A. Oke
Akolade O. Jubril
Saheed Sabiu
author_facet Oluwaseye Adedirin
Rukayat A. Abdulsalam
Khadeejah O. Nasir-Naeem
Ayenitaju A. Oke
Akolade O. Jubril
Saheed Sabiu
author_sort Oluwaseye Adedirin
collection DOAJ
description Type II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. While conventional antihyperglycemic medications like biguanides, sulfonylureas, and other agents are commonly used, their long-term use can have side effects, prompting research into natural alternatives. This study bioprospects the antidiabetic potential of metabolites in Agathosma betulina (Buchu) essential oil through computational analysis of their ability to inhibit protein tyrosine phosphatase 1B (PTP1B), a therapeutic diabetes target. Molecular dynamic simulation, supported by DFT analysis, revealed that compounds linalylanthranilate (−20.18 kcal/mol) and γ-diosphenol (−16.49 kcal/mol) found in the oil exhibited stronger PTP1B inhibition than ursolic acid (−15.98 kcal/mol). The compounds showed favorable drug-like properties complying with Lipinski's rules. This study provides the first evidence that these Buchu oil compounds could potentially serve as PTP1B inhibitors to enhance insulin receptor sensitivity, showing promise for T2DM treatment. Further validation through safety and clinical studies is recommended.
format Article
id doaj-art-b13364e70f644e6e9e65e695944d2811
institution Kabale University
issn 2405-8440
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-b13364e70f644e6e9e65e695944d28112025-02-06T05:12:35ZengElsevierHeliyon2405-84402025-02-01113e42239Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapyOluwaseye Adedirin0Rukayat A. Abdulsalam1Khadeejah O. Nasir-Naeem2Ayenitaju A. Oke3Akolade O. Jubril4Saheed Sabiu5Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South Africa; Corresponding author.Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South AfricaBiotechnology Advanced Research Centre, Sheda Science and Technology Complex, PO Box 186, Garki, Abuja, NigeriaBiotechnology Advanced Research Centre, Sheda Science and Technology Complex, PO Box 186, Garki, Abuja, NigeriaBiotechnology Advanced Research Centre, Sheda Science and Technology Complex, PO Box 186, Garki, Abuja, NigeriaDepartment of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South AfricaType II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. While conventional antihyperglycemic medications like biguanides, sulfonylureas, and other agents are commonly used, their long-term use can have side effects, prompting research into natural alternatives. This study bioprospects the antidiabetic potential of metabolites in Agathosma betulina (Buchu) essential oil through computational analysis of their ability to inhibit protein tyrosine phosphatase 1B (PTP1B), a therapeutic diabetes target. Molecular dynamic simulation, supported by DFT analysis, revealed that compounds linalylanthranilate (−20.18 kcal/mol) and γ-diosphenol (−16.49 kcal/mol) found in the oil exhibited stronger PTP1B inhibition than ursolic acid (−15.98 kcal/mol). The compounds showed favorable drug-like properties complying with Lipinski's rules. This study provides the first evidence that these Buchu oil compounds could potentially serve as PTP1B inhibitors to enhance insulin receptor sensitivity, showing promise for T2DM treatment. Further validation through safety and clinical studies is recommended.http://www.sciencedirect.com/science/article/pii/S240584402500619XDiabetesBuchuEssential oilPTP1BComputational screening
spellingShingle Oluwaseye Adedirin
Rukayat A. Abdulsalam
Khadeejah O. Nasir-Naeem
Ayenitaju A. Oke
Akolade O. Jubril
Saheed Sabiu
Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
Heliyon
Diabetes
Buchu
Essential oil
PTP1B
Computational screening
title Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
title_full Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
title_fullStr Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
title_full_unstemmed Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
title_short Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interventive antidiabetic therapy
title_sort density functional theory and molecular dynamics simulation based bioprospection of agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1b for interventive antidiabetic therapy
topic Diabetes
Buchu
Essential oil
PTP1B
Computational screening
url http://www.sciencedirect.com/science/article/pii/S240584402500619X
work_keys_str_mv AT oluwaseyeadedirin densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy
AT rukayataabdulsalam densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy
AT khadeejahonasirnaeem densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy
AT ayenitajuaoke densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy
AT akoladeojubril densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy
AT saheedsabiu densityfunctionaltheoryandmoleculardynamicssimulationbasedbioprospectionofagathosmabetulinaessentialoilmetabolitesagainstproteintyrosinephosphatase1bforinterventiveantidiabetictherapy